EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenylketonuria—Past, Present, and Future Directions

Nicole A. Bailey, Laura Mackay

OBM Genetics · 16.08.2024 · 08 (03) · 1-21

DOI: 10.21926/obm.genet.2403256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OBM Genetics, online erschienen am 16.08.2024. Verfasst von Nicole A. Bailey und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism with an incidence that varies throughout the world. PKU is caused by loss of function variants in the phenylalanine hydroxylase gene. This loss of function leads to the accumulation of an amino acid, phenylalanine (Phe), that can reach toxic levels in the blood. PKU is managed with a medical diet and sometimes with medication. If diagnosed early and with strict dietary control, neurocognitive deficits can be prevented. There is an important need to ensure the timely diagnosis of PKU and to develop newer therapies to treat this metabolic disorder.

Zitieren

APA

Bailey, N. A., & Mackay, L. (2024). Phenylketonuria—Past, Present, and Future Directions. OBM Genetics, 08(03), 1-21. https://doi.org/10.21926/obm.genet.2403256

Vancouver

Bailey NA, Mackay L. Phenylketonuria—Past, Present, and Future Directions. OBM Genetics. 2024;08(03):1-21. doi:10.21926/obm.genet.2403256

BibTeX
@article{Bailey2024,
  author = {Bailey, Nicole A. and Mackay, Laura},
  title = {Phenylketonuria—Past, Present, and Future Directions},
  journal = {OBM Genetics},
  year = {2024},
  volume = {08},
  number = {03},
  pages = {1--21},
  doi = {10.21926/obm.genet.2403256}
}
Kostenlos starten →